308. Progressive leukoencephalopathy Disease details / Clinical trials / Drug dev / DR info /
Clinical trials : 4 / Drugs : 4 - (DrugBank : 1) / Drug target genes : 5 - Drug target pathways : 2
| Other names | - | ||
|---|---|---|---|
| Disease group | Neuromuscular diseases | ||
|
Domestic patients
Med expenses recipients, FY2024 (corrected) (in Japanese) |
32 patients Age distribution
|
||
| Clinical research form (in Japanese) MHLW Intractable Diseases, FY2026 (in Japanese) | Overview, diagnostic criteria, etc. (pdf), Clinical research form (pdf) 308-01, 308-02, 308-03 | ||
| Specific pediatric chronic diseases, Japan (in Japanese) | - | ||
| Sub-diseases (Clinical research forms may not be available for all sub-diseases.) | No. | Name | Specific pediatric chronic diseases, Japan (in Japanese) |
| 308-1. | Megalencephalic leukoencephalopathy with subcortical cyst; | 11-9-29. megaloencephalic leukoencephalopathy with subcortical cysts | |
| 308-2. | Leukoencephalopathy with vanishing white matter;Vanishing white matter disease; | 11-9-30. vanishing white matter disease | |
| 308-3. | Leukoencephalopathy, progressive, with ovarian failure; | ||
